JPM vs PAI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
PAI presents a compelling value opportunity, characterized by a stable Piotroski F-Score of 5/9 and a significant discount to both its Graham Number ($17.43) and Intrinsic Value ($30.09). While the technical trend is currently bearish (0/100) and insider sentiment is weak, the fundamental valuation metrics—specifically a P/E of 12.01 against a sector average of 34.89 and a Price/Book of 0.93—suggest the asset is heavily undervalued. Strong earnings growth of 26.7% and a sustainable 5.14% dividend yield provide a solid floor for investors.
Compare Another Pair
Related Comparisons
JPM vs PAI: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Western Asset Investment Grade Income Fund Inc. (PAI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.